FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Newsable Asianet News on MSN18 小时
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...
This anti-diabetic drug used for weight loss has been approved by US FDA: When will India ...
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
Alaska Dispatch News6 小时Opinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
The New York Times19 小时
New York Times - Top Stories
U.S. Enters a New Political Era, Defined by Donald Trump The presidential race in 2012 ended a pattern in U.S. politics, which has since become characterized by Mr. Trump’s populism, a Times ...